1. Cheng, Liwei, Zhang, Fan, Wang, Ying, Chen, Jing, Yuan, Xiaoping. 2022. Association between IFNGR1 gene polymorphisms and tuberculosis susceptibility: A meta-analysis. In Frontiers in public health, 10, 976221. doi:10.3389/fpubh.2022.976221. https://pubmed.ncbi.nlm.nih.gov/36148347/
2. Du, Wan, Hua, Fang, Li, Xiong, Fang, Jing-Yuan, Zou, Weiping. 2021. Loss of Optineurin Drives Cancer Immune Evasion via Palmitoylation-Dependent IFNGR1 Lysosomal Sorting and Degradation. In Cancer discovery, 11, 1826-1843. doi:10.1158/2159-8290.CD-20-1571. https://pubmed.ncbi.nlm.nih.gov/33627378/
3. Zheng, Haitao, Xu, Jie, Chu, Yongli, Song, Xicheng, Zhou, Jin. 2022. A Global Regulatory Network for Dysregulated Gene Expression and Abnormal Metabolic Signaling in Immune Cells in the Microenvironment of Graves' Disease and Hashimoto's Thyroiditis. In Frontiers in immunology, 13, 879824. doi:10.3389/fimmu.2022.879824. https://pubmed.ncbi.nlm.nih.gov/35720300/
4. Li, Shiyang, Cao, Xianwei, Guo, Zhuxiu, Tong, Jianbo, Zhang, Zhibin. 2023. Talaromyces marneffei infection with IFNGR1 gene mutation in a patient with negative Anti-Interferon-γ autoantibodies. In Anais brasileiros de dermatologia, 99, 233-237. doi:10.1016/j.abd.2023.03.006. https://pubmed.ncbi.nlm.nih.gov/37926601/
5. van de Vosse, Esther, van Dissel, Jaap T. 2017. IFN-γR1 defects: Mutation update and description of the IFNGR1 variation database. In Human mutation, 38, 1286-1296. doi:10.1002/humu.23302. https://pubmed.ncbi.nlm.nih.gov/28744922/
智鼠故事 
